After kicking off 2023 with a potential megablockbuster in Eisai and Biogen’s new Alzheimer’s drug Leqembi, in totality the FDA signed off on 10 more...
FDA Identified Problems At Moderna Plant Making Substance For COVID Vaccine: Document Authored by Zachary Stieber via The Epoch Times (emphasis...
Top 10 COVID Events Of The Year: Revealing The Facts Unspoken And Unknown Authored by Marina Zhang via The Epoch Times (emphasis ours), COVID-19...
The Ultimate Way To Cut Out Sugar Authored by Flora Zhao via The Epoch Times (emphasis ours), You may have thought of cutting back on or...
Growing Number Of GOP Candidates Pledge To Disavow COVID-19 Vaccine And Big Pharma Authored by Matthew Lysiak via The Epoch Times (emphasis...
CDC Admits No Data Support Advice To Take Mpox, Influenza, And COVID Shots Together Authored by Zachary Stieber via The Epoch Times (emphasis...
A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 15, Issue...
Life is like the changing of seasons, each uniquely beautiful. Just as autumn leaves fall to the ground and make way for winter’s gentle snow, life...
For those working closely with the development of new medicines for FDA approval, it can be informative respecting the future to look back at recent activity...
Investors Alley Let Your Portfolio Go to the Dogs For many Americans, their pets may as well be their children—and they’d do anything to ensure their...
The Unexpected Battle Between Vaccines And The COVID Virus Authored by Yuhong Dong via The Epoch Times (emphasis ours), Since the unprecedented...
Novavax, which has been reeling from a slow rollout of its Covid-19 vaccine compared to the mRNA makers, said it will once again cut costs. Like...
Billions Of Copies Of Residual DNA In A Single Dose Of COVID-19 mRNA Vaccine: Preprint Authored by Marina Zhang via The Epoch Times (emphasis...
"Enough Is Enough": Widower Sues Hospital for Withholding Ivermectin, Claims Wrongful Death The family of a woman who died after a hospital...
Moderna is turning its Covid-19 vaccine brand name Spikevax into a verb in its first ad campaign. The debut TV ad — which includes an upbeat...
In September, Invivyd dosed its first patient in the Phase III CANOPY pivotal trial (NCT06039449), designed to assess VYD222’s ability to protect against...
FDA Responds After Being Urged To Recall Pfizer's Vaccine Over DNA Fragments Authored by Zachary Stieber via The Epoch Times (emphasis ours), The...
“The patient was managed with ripretinib and surgical resection of progressing lesions at multiple time points which led to extended clinical benefit.”...
Novartis says that access to Pluvicto is now “fully unconstrained” as the pharma giant plans for manufacturing expansions to ensure a steady supply...
Novartis says that access to Pluvicto is now “fully unconstrained” as the pharma giant plans for manufacturing expansions to ensure a steady supply...
The Covid boom is over at Moderna. On Thursday, the biotech said it was bracing for sales to “hit a low point” in 2024 as demand...
Novartis recently said that sales of its radiopharmaceutical Pluvicto came in lower than expected in the third quarter as a result of manufacturing issues,...
Novartis recently said that sales of its radiopharmaceutical Pluvicto came in lower than expected in the third quarter as a result of manufacturing issues,...
Penny stocks to buy according to analysts The post 7 Penny Stocks To Buy Now According To Analysts, Targets Up To 751% appeared first on Penny...
Penny stocks to buy according to analysts The post 7 Penny Stocks To Buy Now According To Analysts, Targets Up To 751% appeared first on Penny...
Researchers at MUSC Hollings Cancer Center believe that some drugs already approved by the U.S. Food and Drug Administration or currently in clinical...
Eli Lilly raked in $9.5 billion in sales in the third quarter, shooting up 37% year-over-year thanks in part to growing sales of its new type...
Seres Therapeutics will end most R&D work to focus resources on its commercial product in a move that will result in letting go about 160 workers,...
INDIANAPOLIS — A recent study led by Indiana University School of Medicine in collaboration with the University of Chicago Medicine presents exciting...
The FDA approval of Amgen’s interchangeable Stelara biosimilar is raising broader questions about how potential competition could impact Medicare price...